Strategic Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.4M Buy
2,615
+590
+29% +$598K 0.17% 67
2025
Q4
$2.18M Sell
2,025
-95
-4% -$90.8K 0.19% 62
2025
Q3
$1.62M Sell
2,120
-186
-8% -$138K 0.15% 74
2025
Q2
$1.79M Sell
2,306
-201
-8% -$156K 0.17% 64
2025
Q1
$2.07M Sell
2,507
-74
-3% -$61.6K 0.22% 61
2024
Q4
$1.99M Buy
2,581
+134
+5% +$111K 0.21% 64
2024
Q3
$2.17M Sell
2,447
-60
-2% -$53.9K 0.24% 57
2024
Q2
$2.27M Sell
2,507
-6
-0.2% -$4.8K 0.28% 56
2024
Q1
$1.96M Sell
2,513
-67
-3% -$47.7K 0.25% 60
2023
Q4
$1.5M Buy
2,580
+346
+15% +$202K 0.22% 67
2023
Q3
$1.2M Buy
2,234
+229
+11% +$118K 0.2% 76
2023
Q2
$940K Sell
2,005
-201
-9% -$84.3K 0.13% 76
2023
Q1
$758K Buy
2,206
+222
+11% +$74.9K 0.14% 117
2022
Q4
$726K Sell
1,984
-3,554
-64% -$1.26M 0.15% 117
2022
Q3
$1.79M Buy
5,538
+521
+10% +$165K 0.4% 46
2022
Q2
$1.63M Buy
5,017
+352
+8% +$106K 0.33% 53
2022
Q1
$1.34M Buy
4,665
+776
+20% +$200K 0.25% 71
2021
Q4
$1.07M Buy
3,889
+450
+13% +$114K 0.21% 98
2021
Q3
$794K Buy
3,439
+249
+8% +$61.5K 0.17% 122
2021
Q2
$732K Sell
3,190
-2,817
-47% -$566K 0.17% 122
2021
Q1
$1.12M Sell
6,007
-5,456
-48% -$1.07M 0.29% 74
2020
Q4
$1.94M Buy
11,463
+8,766
+325% +$1.31M 0.56% 45
2020
Q3
$397K Buy
2,697
+1,202
+80% +$186K 0.13% 109
2020
Q2
$245K Buy
+1,495
New +$229K 0.09% 156

Other funds holding LLY

Strategic Investment Advisors's LLY Position: Q1 2026 in Review

Strategic Investment Advisors increased its Eli Lilly (LLY) stake by 29% in Q1 2026, buying an estimated $598K and bringing the position to 2,615 shares worth $2.4M. The position accounts for 0.17% of the portfolio, ranked #67.

Strategic Investment Advisors first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Strategic Investment Advisors held 2,615 shares of Eli Lilly worth $2.4M as of Q1 2026.
  • Strategic Investment Advisors bought 590 Eli Lilly shares in Q1 2026, an estimated $598K.
  • Eli Lilly made up 0.17% of Strategic Investment Advisors's portfolio in Q1 2026, its #67 holding.
  • Strategic Investment Advisors first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Strategic Investment Advisors's 13F filing for Q1 2026, filed 18 May 2026.